These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22920041)

  • 1. Update on emerging drugs for insomnia.
    Sullivan S
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):295-8. PubMed ID: 22920041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs for insomnia.
    Zisapel N
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):299-317. PubMed ID: 22681198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time.
    Wafford KA; Ebert B
    Nat Rev Drug Discov; 2008 Jun; 7(6):530-40. PubMed ID: 18511929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for insomnia: new frontiers for old and novel targets.
    Sullivan SS; Guilleminault C
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):411-22. PubMed ID: 19708818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia.
    Roecker AJ; Mercer SP; Schreier JD; Cox CD; Fraley ME; Steen JT; Lemaire W; Bruno JG; Harrell CM; Garson SL; Gotter AL; Fox SV; Stevens J; Tannenbaum PL; Prueksaritanont T; Cabalu TD; Cui D; Stellabott J; Hartman GD; Young SD; Winrow CJ; Renger JJ; Coleman PJ
    ChemMedChem; 2014 Feb; 9(2):311-22. PubMed ID: 24376006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of orexin receptor antagonists as therapeutics for insomnia.
    Winrow CJ; Renger JJ
    Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of [(2R,5R)-5-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): a dual orexin receptor antagonist with potent sleep-promoting properties.
    Coleman PJ; Schreier JD; Cox CD; Breslin MJ; Whitman DB; Bogusky MJ; McGaughey GB; Bednar RA; Lemaire W; Doran SM; Fox SV; Garson SL; Gotter AL; Harrell CM; Reiss DR; Cabalu TD; Cui D; Prueksaritanont T; Stevens J; Tannenbaum PL; Ball RG; Stellabott J; Young SD; Hartman GD; Winrow CJ; Renger JJ
    ChemMedChem; 2012 Mar; 7(3):415-24, 337. PubMed ID: 22307992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.
    Atkin T; Comai S; Gobbi G
    Pharmacol Rev; 2018 Apr; 70(2):197-245. PubMed ID: 29487083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of insomnia. Pharmacological approaches and their limitations].
    Costentin J
    Bull Acad Natl Med; 2011 Oct; 195(7):1583-94; discussion 1594-5. PubMed ID: 22812162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suvorexant for the treatment of insomnia.
    Jacobson LH; Callander GE; Hoyer D
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):711-30. PubMed ID: 25318834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological advances in the treatment of insomnia.
    Richey SM; Krystal AD
    Curr Pharm Des; 2011; 17(15):1471-5. PubMed ID: 21476952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and emerging pharmacotherapeutic approaches for insomnia.
    Neubauer DN
    Int Rev Psychiatry; 2014 Apr; 26(2):214-24. PubMed ID: 24892896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present status and future of hypnotic drug treatment for insomnia].
    Uchiyama M; Konno M
    Nihon Rinsho; 2012 Jul; 70(7):1241-51. PubMed ID: 22844812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics.
    Nutt DJ; Stahl SM
    J Psychopharmacol; 2010 Nov; 24(11):1601-12. PubMed ID: 19942638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
    Staner L; Danjou P; Luthringer R
    Expert Rev Neurother; 2012 Feb; 12(2):141-53. PubMed ID: 22288669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel insomnia drugs, including drugs currently under development].
    Inada K
    Nihon Rinsho; 2009 Aug; 67(8):1590-4. PubMed ID: 19768946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin receptor antagonists.
    Christopher JA
    Pharm Pat Anal; 2012 Jul; 1(3):329-46. PubMed ID: 24236845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suvorexant: something new for sleep?
    Reddy A; Puvvada SC; Kommisetti S; El-Mallakh RS; Lippmann S
    Acta Neuropsychiatr; 2015 Feb; 27(1):53-5. PubMed ID: 25397996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Phase II investigational therapies for insomnia.
    Zisapel N
    Expert Opin Investig Drugs; 2015 Mar; 24(3):401-11. PubMed ID: 25423562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose doxepin for the treatment of insomnia: emerging data.
    Goforth HW
    Expert Opin Pharmacother; 2009 Jul; 10(10):1649-55. PubMed ID: 19496739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.